Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity
- PMID: 35836263
- PMCID: PMC9281075
- DOI: 10.1186/s12979-022-00288-7
Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity
Abstract
The aging process can have detrimental effects on the immune system rendering the elderly more susceptible to infectious disease and less responsive to vaccination. Major depressive disorder (MDD) has been hypothesized to show characteristics of accelerated biological aging. This raises the possibility that depressed individuals will show some overlap with elderly populations with respect to their immune response to infection and vaccination. Here we provide an umbrella review of this literature in the context of the SARS CoV-2 pandemic. On balance, the available data do indeed suggest that depression is a risk factor for both adverse outcomes following COVID-19 infection and for reduced COVID-19 vaccine immunogenicity. We conclude that MDD (and other major psychiatric disorders) should be recognized as vulnerable populations that receive priority for vaccination along with other at-risk groups.
Keywords: Aging; Depression; Immunosenescence; Inflammaging; Psychiatric disorders; SARS CoV-2; Vaccine immunogenicity.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.Front Immunol. 2020 Aug 7;11:1748. doi: 10.3389/fimmu.2020.01748. eCollection 2020. Front Immunol. 2020. PMID: 32849623 Free PMC article. Review.
-
Immunosenescence, Inflammaging and Resilience: An Evolutionary Perspective of Adaptation in the Light of COVID-19 Pandemic.Psychiatr Danub. 2021 Spring-Summer;33(Suppl 4):427-431. Psychiatr Danub. 2021. PMID: 34718260
-
The Role of Immunosenescence and Inflammaging in the Susceptibility of Older Adults to SARS-CoV-2 Infection.Curr Pharm Biotechnol. 2025 Feb 13. doi: 10.2174/0113892010328697250210065420. Online ahead of print. Curr Pharm Biotechnol. 2025. PMID: 39949104
-
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19.Immun Ageing. 2022 Nov 11;19(1):53. doi: 10.1186/s12979-022-00309-5. Immun Ageing. 2022. PMID: 36369012 Free PMC article. Review.
-
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1. Trials. 2021. PMID: 33849629 Free PMC article.
Cited by
-
Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study.Signal Transduct Target Ther. 2024 May 13;9(1):129. doi: 10.1038/s41392-024-01846-9. Signal Transduct Target Ther. 2024. PMID: 38740763 Free PMC article.
-
Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions.Immun Ageing. 2023 Apr 12;20(1):17. doi: 10.1186/s12979-023-00341-z. Immun Ageing. 2023. PMID: 37046272 Free PMC article. Review.
-
Kinetics of pro- and anti-inflammatory spike-specific cellular immune responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: a prospective longitudinal study in Japan.Immun Ageing. 2024 Jun 22;21(1):41. doi: 10.1186/s12979-024-00444-1. Immun Ageing. 2024. PMID: 38909235 Free PMC article.
-
Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: a prospective longitudinal study in Japan.Immun Ageing. 2023 Aug 17;20(1):42. doi: 10.1186/s12979-023-00368-2. Immun Ageing. 2023. PMID: 37592283 Free PMC article.
-
Gene Age Gap Estimate (GAGE) for major depressive disorder: a penalized biological age model using gene expression.bioRxiv [Preprint]. 2024 Nov 17:2024.09.03.610913. doi: 10.1101/2024.09.03.610913. bioRxiv. 2024. Update in: Neurobiol Aging. 2025 Jul;151:13-21. doi: 10.1016/j.neurobiolaging.2025.01.012. PMID: 39282409 Free PMC article. Updated. Preprint.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous